Cynata

Cynata Therapeutics – Producing Stem Cells for Regenerative Medicine ...

Cynata Therapeutics to talk stem cell therapies at Proactive’s CEO ...

Cynata Therapeutics

Cynata recruits first respiratory patient for stem cells clinical trial ...

Cynata Therapeutics opens first US site in Phase 2 CYP-001 trial - YouTube

How Cynata Therapeutics is accelerating iPSC therapeutics ...

Cynata Approved to Launch World’s 1st Clinical Trial with an Allogeneic ...

#stemcelltherapy #medicaladvancements | Cynata Therapeutics

Cynata Therapeutics (ASX:CYP) is advancing Cymerus™️, a proprietary ...

Exciting positive results coming out of Cynata Therapeutics! And ...

Cynata Approved to Launch World’s 1st Clinical Trial with an Allogeneic ...

Cynata Approved to Launch World’s 1st Clinical Trial with an Allogeneic ...

Cynata Therapeutics jumps as FDA OK’s stem cell rejection treatment

Cynata is changing the future of medical treatment through a ...

Cynata Therapeutics Ltd to talk stem cell therapies at Proactive’s CEO ...

Cynata achieves world-first stem cell manufacturing breakthrough

Cynata stem cell technology a triumph: scientist | Stockhead

Cynata Therapeutics advances Stem Cell Therapy for rare disease with ...

Cynata Therapeutics Ltd wins U.S. patent for stem cell technology

Cynata to expand recruitment criteria in Covid-19 treatment trial

Cynata CYP-001 Stem Cell Therapy Meets All Safety and

Cynata Therapeutics gets $1 M grant to develop heart disease treatment

Cynata raises $15 million to fast-track stem cell therapies | The West ...

Cynata Therapeutics jumps as FDA OK’s stem cell rejection treatment

Cynata includes coronary artery disease into existing stem cell therapy ...

Cynata stem cells test positive for heart attack repair | The West ...

Jolanta Airey - Cynata Therapeutics - A Next-Generation Stem Cell ...

Cynata recruits first patient for Phase 2 trial of stem cells for graft ...

Cynata seals partnership for US stem cell therapy push | The West ...

Sistemic and Cynata Announce Cooperation on In-process Purity Assay ...

Why invest in stem cell therapies? 🧬💉 Cynata is a clinical stage ...

Cynata looking to revolutionise stem cell therapy | The West Australian

Aussie Stem Cell Company Cynata Therapeutics Signs LOI with apceth GmbH

Cynata completes enrolment in Phase II trial | The Australian

Cynata adding target indications : r/CynataTherapeutics

Cynata to Launch First Phase 3 Trial with iPSC-Derived Cell Therapeutic

Cynata Therapeutics finalises Cymerus patent to treat adverse reactions ...

Biotechnology News - Cynata enters into new manufacturing partnership ...

Cynata Therapeutics Limited

Cynata Stem Cell Technology - YouTube

ASX:CYP - Cynata Presenting at Advanced Therapies Congress

Cynata Therapeutics' breakthrough in regenerative medicine - Sequoia Direct

Cynata Shares Jump as Japan's FUJIFILM Negotiates Deal to Commercialize ...

Cynata Therapeutics opens first US site in Phase 2 CYP-001 trial | ASX:CYP

Cynata launches diabetic foot ulcer clinical trial | The West Australian

Cynata Therapeutics (ASX:CYP) | Webinar with Dr Kilian Kelly | 27/06/24 ...

Cynata Therapeutics on LinkedIn: #stemcells #celltherapy #clinicaltrial

Cynata Therapeutics: A $100m deal with big Pharma – now that’s remarkable!

Cynata Therapeutics Initiates Patient Treatment in World 1st Clinical ...

Cynata Therapeutics (ASX: CYP) gears up for clinical progress after ...

ASX Announcements | Cynata Therapeutics

How Cynata Therapeutics is Unlocking the Power of iPSCs to Transform ...

Cynata Shares Jump as Japan's FUJIFILM Negotiates Deal to Commercialize ...

Emerging Stocks Down Under 8 December 2020: Cynata Therapeutics ...

Cynata Therapeutics' (ASX:CYP) clinical trials gaining pace | Kalkine ...

Cynata Therapeutics Lands Japanese Giant Fujifilm

Cynata Therapeutics (ASX:CYP) talks stem cell trials & partnerships ...

Dr. Kilian Kelly, Ph.D. — CEO, Cynata Therapeutics — iPSC-Derived ...

Cynata Therapeutics elaborates on its strong pipeline of clinical ...

Cynata Therapeutics on LinkedIn: #cynata #clinicaltrial # ...

What's ahead for stem cell play Cynata after that huge run | Stockhead

Cynata Therapeutics' Pivotal Year Ahead with Osteoarthritis and aGvHD ...

msemporda: Cynata & The Rubik of Cell Science

Cynata Therapeutic’s Cymerus™ iPSC-MSC Manufacturing Platform : r ...

Cynata Therapeutics (ASX: CYP) gears up for clinical progress after ...

Cynata Therapeutics on LinkedIn: Did you know that mesenchymal stem ...

Cynata Therapeutics treats first patient in aGvHD drug trial

Cynata Therapeutics (ASX:CYP) is making steady progress: Interview with ...

Cynata Introduces Critical Innovation into MSC Manufacturing | BioInformant

How Cynata Therapeutics is Unlocking the Power of iPSCs to Transform ...

Cynata Therapeutics to Test Proprietary MSC Manufacturing Process in ...

Cynata Therapeutics, Behind the Scenes with CEO Dr. Ross Macdonald

Cynata Therapeutics Lands Japanese Giant Fujifilm

Cynata Therapeutics - YouTube

The Sentiment on LinkedIn: Cynata Therapeutics advances Stem Cell ...

msemporda: Cynata & The Rubik of Cell Science

Cynata Therapeutics Initiates Patient Treatment in World 1st Clinical ...

Cynata Therapeutics Secures $6M in Capital Raise, $10M with Payment ...

Home | Cynata Therapeutics

Cynata Approved to Launch World’s 1st Clinical Trial with an Allogeneic ...

Cynata Therapeutics reveals more positive pre-clinical cancer trial results

Cynata Approved to Launch World’s 1st Clinical Trial with an Allogeneic ...

Cynata Therapeutics Initiates Patient Treatment in World 1st Clinical ...

Cynata approval for 1st ever allo trial of IPSC-derived MSCs for GVHD ...

Cynata Therapeutics' breakthrough in regenerative medicine - YouTube

Cynata to Launch First Phase 3 Trial with iPSC-Derived Cell Therapeutic

Cynata Therapeutics Initiates Patient Treatment in World 1st Clinical ...

Cynata’s Stem Cell Therapy Meets All Safety & Efficacy Endpoints in Trial

FujiFilm - Cynata's First Licensee Of Its Lead Product CYP-001 In GvHD ...

Great work from Louise Smith and her team from TekCyte Limited using ...

TechInvest

Cynata’s iPSC-derived Cell Therapeutic (CYP-001) Meets Safety ...

FujiFilm - Cynata's First Licensee Of Its Lead Product CYP-001 In GvHD ...

Patient Treatment Commences in Cynata’s World First Clinical Trial (CYP ...

Scalable MSC platform enabling next wave of stem cell therapies with Dr ...

SPECIAL FEATURE - Platform Technologies - Derisking & Transforming Drug ...

Fuji’s expected licensing will be significant validation of Cynata’s ...

Want to stay informed about Cynata's innovative approach to ...

Cynata's Collaboration With Rasko Lab - More Than "Just" CYP-001 in SR ...

CynataTherapeutics

Clinical trials are an integral part of developing new therapeutic ...

FUJIFILM Cellular Dynamics would like to congratulate our partners at ...

Cynata's stem cell tech verified in peer-reviewed study | 2025-02-05 ...

Patient Treatment Commences in Cynata’s World First Clinical Trial (CYP ...

#advancedtherapiescongress #regenerativemedicine #stemcells #biotech # ...

#isct2025 #celltherapy #regenerativemedicine #ipscs #stemcells #biotech ...

Advanced Stem Cell Manufacture Saves Lives & Prints Money: Stewart ...

We're honoured to be featured in a recent report discussing the global ...

Full article: Industry Updates from the Field of Stem Cell Research and ...

Cynata’s CYP-001 shows positive safety profile | The Australian

With MSCs gradually gaining therapeutic interest as they show ...

CynataのCymerus™プラットフォームテクノロジー - それは何か？ | BioInformant

Enrolment of First Cohort Completed with Eighth Participant Dosed in ...

We're thrilled to be named as one to watch by Bioshares among ...

Patient Enrolment Complete in Phase 2 aGvHD Clinical Trial | BioInformant

Revolutionizing Heart Disease Treatment with iPSC-Derived MSCs ...

Cynata’s MSC Technology Demonstrates Significant Efficacy in ...

Cynata’s CYP-001 shows positive safety profile | The Australian

US FDA Clears IND for Cynata’s Phase 2 Clinical Trial of CYP-001 in ...